1966
DOI: 10.1073/pnas.56.2.709
|View full text |Cite
|
Sign up to set email alerts
|

Development of cytokinin activity by rearrangement of 1-substituted adenines to 6-substituted aminopurines: inactivation by N6, 1-cyclization.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

1966
1966
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(8 citation statements)
references
References 9 publications
0
8
0
Order By: Relevance
“…A plausible mechanism to account for the biological origin of N 6 -TbAd is that 1-TbAd is converts to N 6 -TbAD by a Dimroth rearrangement, which involves attack of a nucleophile (such as hydroxide or an amine) at C-2 to form a ring-opened intermediate followed by ring closure by the unsubstituted nitrogen to give the N 6 -linked form (Figure 5A), (El Ashry et al, 2010; Fujii and Itaya, 1998; Grimm and Leonard, 1967; Leonard et al, 1966; Macon and Wolfenden, 1968; Ottria et al, 2010; Snyder and Adams, 2011). Products from recombinant Rv3378c enzyme showed a strong signal for 1-TbAd and no signal for N 6 -TbAd, demonstrating that the latter is not a primary product of this enzyme (Figure 5B).…”
Section: Resultsmentioning
confidence: 99%
“…A plausible mechanism to account for the biological origin of N 6 -TbAd is that 1-TbAd is converts to N 6 -TbAD by a Dimroth rearrangement, which involves attack of a nucleophile (such as hydroxide or an amine) at C-2 to form a ring-opened intermediate followed by ring closure by the unsubstituted nitrogen to give the N 6 -linked form (Figure 5A), (El Ashry et al, 2010; Fujii and Itaya, 1998; Grimm and Leonard, 1967; Leonard et al, 1966; Macon and Wolfenden, 1968; Ottria et al, 2010; Snyder and Adams, 2011). Products from recombinant Rv3378c enzyme showed a strong signal for 1-TbAd and no signal for N 6 -TbAd, demonstrating that the latter is not a primary product of this enzyme (Figure 5B).…”
Section: Resultsmentioning
confidence: 99%
“…However, some treatments, including heating, convert them into active compounds (21,43). A recent study (23) combining the highly specific tobacco callus bioassay with a sys- (2).…”
Section: Biological Ffects Of Cytokdninsmentioning
confidence: 99%
“…Leonard and Fujii (56) noticed that such a substituent directed alkylation to the 1-position and thereby produced another good synthesis for 1-substituted adenines. Furthermore, the 1-substituted compounds easily rearrange to Nff-substituted (43). Recently Grimm and Leonard prepared 6 -(y,'y-dimethylallylamino) -9 -,8-D-ribofuranosyl purine-5'-phosphate by alkylation of the sodium salt of AMP and subsequent rearrangement of the 1-isomer to the N6-compound (59) (Fig.…”
Section: Chemical and Biological Synthesismentioning
confidence: 99%
See 1 more Smart Citation
“…N 6 -alkylation of adenosine derivatives is mainly achieved through aromatic nucleophilic substitution (S N Ar) of diverse electrophilic adenosine derivatives [ 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 ] or by Dimroth rearrangement of 1- N -alkylated adenosines [ 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 ]. In the context of S N Ar, synthetic strategies involving non classic leaving groups were developed using peptide-coupling agents for activation of the amide group of inosine derivatives [ 53 , 54 , 55 , 56 ].…”
Section: Introductionmentioning
confidence: 99%